GlassScriptPhysician profile
Justyn D Blankenship
NPI 1639605124
$2,893.55
in general payments reported to CMS, 2019-2025
23 companies · $826 in 2025
The $826 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $104 · 2022: $303 · 2023: $819 · 2024: $633 · 2025: $826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,278.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $633.17 | 2019-2025 | Lithovue Elite, Ams 700, Lithoclast |
| Endo USA, INC. | $322.70 | 2024-2025 | Xiaflex |
| Procept Biorobotics Corporation | $242.24 | 2023 | Aquabeam Robotic System |
| Janssen Biotech, INC. | $232.03 | 2022-2024 | Erleada |
| Sumitomo Pharma America, INC. | $212.95 | 2023-2025 | Gemtesa |
| Convatec INC. | $207.20 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $175.89 | 2023-2025 | Prolaris |
| Endo Pharmaceuticals INC. | $134.31 | 2022-2024 | Xiaflex |
| Astellas Pharma US INC | $114.36 | 2022-2025 | Xtandi, Myrbetriq |
| Pfizer INC. | $105.07 | 2024-2025 | |
| Olympus America INC. | $81.17 | 2025 | Itind System |
| Urogen Pharma, INC. | $72.67 | 2025 | |
| Axonics, INC. | $60.58 | 2022 | |
| Laborie Medical Technologies Corp. | $49.78 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Foundation Medicine, INC. | $47.34 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $47.20 | 2025 | |
| Abbvie INC. | $32.37 | 2025 | |
| Telix Pharmaceuticals | $27.24 | 2024 | Illuccix |
| Progenics Pharmaceuticals, INC. | $24.30 | 2025 | |
| Medtronic, INC. | $22.90 | 2022 | |
| Hollister Incorporated | $19.92 | 2023 | Vapro Plus Pocket, Infyna Chic, Onli |
| Urovant Sciences INC | $14.13 | 2022 | |
| Halozyme INC | $14.03 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justyn Blankenship listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.